Thomas Civik
Chairman
Pyxis Oncology, Inc. (PYXS)Board Member
Pyxis Oncology, Inc. (PYXS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas Civik
Thomas Civik is recorded as CEO, Chairman and Board Member at Pyxis Oncology, Inc. (PYXS). Pyxis Oncology, Inc. reported in an 8-K filed September 8, 2026 that Thomas Civik was appointed Chairman of the Board, effective September 4, 2026. Pyxis Oncology, Inc. reported in an 8-K filed September 8, 2026 that Thomas Civik was appointed Chief Executive Officer, effective September 4, 2026.
“the Board determined to combine the roles of Chairman of the Board and Chief Executive Officer and appointed Mr. Civik as Chairman of the Board, effective September 4, 2026.”
“On September 4, 2026, the Board of Directors (the "Board") of Pyxis Oncology, Inc. (the "Company") appointed Thomas Civik, the Company's Interim Chief Executive Officer, to serve as the Company's permanent Chief Executive Officer, effective immediately (the "Appointment").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-04–present
-
Current
2021-01-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pyxis Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Pamela Connealy COO
- Jitendra Wadhane Chief Accounting Officer
- Jakob Dupont, M.D. Board Member
- Michael A. Metzger Board Member
- Rachel Humphrey, M.D. Board Member
- Santhosh Palani, Ph.D., CFA Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.